Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-020375

President and CEO sold 5,142 shares at $8.06 ($41,445)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Luly Jay R. President and CEO 2024-12-06 Sale 10b5-1 −5,142 $8.06 $41,445 801,638 D
Open-market sales · 5,142 sh · avg $8.06 · $41,445
Loading xslF345X05/form4.xml…